These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28006859)
1. Pure erythroid leukemia. Wang W; Wang SA; Medeiros LJ; Khoury JD Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859 [TBL] [Abstract][Full Text] [Related]
2. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413 [TBL] [Abstract][Full Text] [Related]
3. Erythroid proliferations in myeloid neoplasms. Wang SA; Hasserjian RP Hum Pathol; 2012 Feb; 43(2):153-64. PubMed ID: 22154053 [TBL] [Abstract][Full Text] [Related]
4. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities. Wang SA; Hasserjian RP Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461 [TBL] [Abstract][Full Text] [Related]
5. The disappearance of acute erythroid leukemia: An act of legerdemain at the World Health Organization. Lichtman MA Blood Cells Mol Dis; 2016 Oct; 61():54-7. PubMed ID: 27667167 [No Abstract] [Full Text] [Related]
6. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification. Liu CJ; Hong YC; Yang CF; Liu SH; Gau JP; Liu JH; Hsiao LT; Liu CY; Yu YB; Tzeng CH Leuk Lymphoma; 2012 Feb; 53(2):289-94. PubMed ID: 21780998 [TBL] [Abstract][Full Text] [Related]
10. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492 [TBL] [Abstract][Full Text] [Related]
11. Correspondence re: Brunning R: Proposed WHO classification of acute myeloid leukemia and myelodysplastic syndromes. Mod Pathol 1999;1:102-4. Mazzella FM; Cotelingam JD; Kowal-Vern A; Shrit MA; Rector JT; Alvares C; Schumacher HR Mod Pathol; 2000 Jan; 13(1):101-2. PubMed ID: 10658917 [No Abstract] [Full Text] [Related]
12. Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification. Chen Y; Pourabdollah M; Atenafu EG; Tierens A; Schimmer A; Chang H Leuk Res; 2017 Oct; 61():39-43. PubMed ID: 28886412 [TBL] [Abstract][Full Text] [Related]
13. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. Alkharabsheh O; Al-Kali A; Saadeh S; He R; Viswanatha D; Greipp P; Reichard K; Shah M; Gangat N; Patnaik M; Hogan W; Litzow M; Alkhateeb H; Nguyen PL Am J Hematol; 2018 Nov; 93(11):E355-E357. PubMed ID: 30074268 [No Abstract] [Full Text] [Related]
14. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice. Di Genua C; Nerlov C Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869 [TBL] [Abstract][Full Text] [Related]
15. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273 [TBL] [Abstract][Full Text] [Related]
16. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification. Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875 [TBL] [Abstract][Full Text] [Related]
18. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia. Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583 [TBL] [Abstract][Full Text] [Related]
19. Erythroleukemia and myelodysplastic syndromes: an historical appraisal and a personal view. Michiels JJ Leuk Lymphoma; 1993 Jan; 9(1-2):27-34. PubMed ID: 8477198 [No Abstract] [Full Text] [Related]
20. Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance. Pourabdollah M; Chang H Blood; 2017 Feb; 129(7):918. PubMed ID: 28209754 [No Abstract] [Full Text] [Related] [Next] [New Search]